Journal Article

Acute and Long COVID Intestinal Changes in an Experimental Model of Coronavirus in Mice

Rashed, Amirah B., Paidas, Michael J., Druyan, Brian Zachary, Shamaladevi, Nagarajarao, Ramamoorthy, Rajalakshmi, Elumalai, Nila, Jayakumar, Arumugam R., Kenyon, Norma S., Sampath, Natarajan, Hussain, Hussain, Hajjar, Rima

2024

Overview

The COVID-19 pandemic, which emerged in early 2020, has had a profound and lasting impact on global health, resulting in over 7.0 million deaths and persistent challenges. In addition to acute concerns, there is growing attention being given to the long COVID health consequences for survivors of COVID-19 with documented cases of cardiovascular abnormalities, liver disturbances, lung complications, kidney issues, and noticeable cognitive deficits. Recent studies have investigated the physiological changes in various organs following prolonged exposure to murine hepatitis virus-1 (MHV-1), a coronavirus, in mouse models. One significant finding relates to the effects on the gastrointestinal tract, an area previously understudied regarding the long-lasting effects of COVID-19. This research sheds light on important observations in the intestines during both the acute and the prolonged phases following MHV-1 infection, which parallel specific changes seen in humans after exposure to SARS-CoV-2. Our study investigates the histopathological alterations in the small intestine following MHV-1 infection in murine models, revealing significant changes reminiscent of inflammatory bowel disease (IBD), celiac disease. Notable findings include mucosal inflammation, lymphoid hyperplasia, goblet cell hyperplasia, and immune cell infiltration, mirroring pathological features observed in IBD. Additionally, MHV-1 infection induces villous atrophy, altered epithelial integrity, and inflammatory responses akin to celiac disease and IBD. SPIKENET (SPK) treatment effectively mitigates intestinal damage caused by MHV-1 infection, restoring tissue architecture and ameliorating inflammatory responses. Furthermore, investigation into long COVID reveals intricate inflammatory profiles, highlighting the potential of SPK to modulate intestinal responses and restore tissue homeostasis. Understanding these histopathological alterations provides valuable insights into the pathogenesis of COVID-induced gastrointestinal complications and informs the development of targeted therapeutic strategies.

• Publisher: MDPI AG,MDPI
• Subject: Animal models / Animals / Atrophy / Celiac disease / cognition / Coronaviruses / COVID-19 / COVID-19 - immunology / COVID-19 - pathology / COVID-19 - virology / COVID-19 infection / digestive tract / Disease Models, Animal / Enzymes / epithelium / Ethanol / Female / fibrosis / Gastrointestinal diseases / Gastrointestinal tract / goblet cell / Hepatitis / histopathology / Homeostasis / Host-virus relationships / Hyperplasia / infection / Infections / Inflammation / Inflammatory bowel disease / Inflammatory bowel diseases / Intestinal Mucosa - pathology / Intestinal Mucosa - virology / intestine / Intestine, Small - pathology / Intestine, Small - virology / Intestines - pathology / Intestines - virology / kidneys / liver / Long COVID / lungs / Mice / Mortality / Mucosal immunity / Murine hepatitis virus - pathogenicity / Pandemics / pathogenesis / pili / Public health / Risk factors / SARS-CoV-2 - pathogenicity / Severe acute respiratory syndrome coronavirus 2 / Small intestine / therapeutics / Viral infections